Ram Waisbourd News Today : Breaking News, Live Updates & Top Stories | Vimarsana

89bio (NASDAQ:ETNB – Get Rating) had its price target lowered by research analysts at SVB Leerink from $62.00 to $50.00 in a research report issued to clients and investors on Friday, Benzinga reports. The brokerage presently has an “outperform” rating on the stock. A number of other brokerages have also weighed in on ETNB. Zacks […] ....

United States , Ram Waisbourd , Securities Exchange Commission , Goldman Sachs Group Inc , Zacks Investment Research , Sg Americas Securities , Wells Fargo Company , Orbimed Advisors Llc , Citigroup Inc , Get Rating , Investment Research , Exchange Commission , Sachs Group , California State Teachers Retirement System , State Teachers Retirement System , Nasdaq Etnb , Lower Price Target , Svb Leerink Llc ,